BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shao C, Ye J, Li F, Feng S, Wang W, Zhong B. Different predictors of steatosis and fibrosis severity among lean, overweight and obese patients with nonalcoholic fatty liver disease. Digestive and Liver Disease 2019;51:1392-9. [DOI: 10.1016/j.dld.2019.02.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Basaranoglu M. Lean and Nonobese NAFLD/NASH From a Hepatologist's Point of View. J Clin Gastroenterol 2021;55:93-4. [PMID: 32925302 DOI: 10.1097/MCG.0000000000001428] [Reference Citation Analysis]
2 Ye Q, Zou B, Yeo YH, Li J, Huang DQ, Wu Y, Yang H, Liu C, Kam LY, Tan XXE, Chien N, Trinh S, Henry L, Stave CD, Hosaka T, Cheung RC, Nguyen MH. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5:739-752. [PMID: 32413340 DOI: 10.1016/s2468-1253(20)30077-7] [Cited by in Crossref: 85] [Cited by in F6Publishing: 38] [Article Influence: 42.5] [Reference Citation Analysis]
3 Wu T, Ye J, Shao C, Li F, Lin Y, Ma Q, Wang W, Feng S, Zhong B. Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease. Front Endocrinol (Lausanne) 2021;12:691556. [PMID: 34899591 DOI: 10.3389/fendo.2021.691556] [Reference Citation Analysis]
4 Khamseh ME, Malek M, Abbasi R, Taheri H, Lahouti M, Alaei-Shahmiri F. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity. Metab Syndr Relat Disord 2021;19:167-73. [PMID: 33259744 DOI: 10.1089/met.2020.0109] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Sengul C, Cakir C, Barutcu S, Sarikaya R. The prevalence and correlates of T-wave inversion in lead III in non-obese men. J Electrocardiol 2020;61:66-70. [PMID: 32554158 DOI: 10.1016/j.jelectrocard.2020.05.008] [Reference Citation Analysis]
6 Lonardo A, Targher G. Cardiovascular Risk in NAFLD: An Intimate Relationship? Dig Dis Sci 2020;65:1593-5. [DOI: 10.1007/s10620-019-05996-7] [Reference Citation Analysis]
7 Lorena M, Bellan M, Lepore M, Sola D, Pedrazzoli R, Rigamonti C, De Benedittis C, Manfredi GF, Acquaviva A, Tonello S, Rizzi M, Minisini R, Pirisi M, Sainaghi PP. Clinical Relevance of Liver Involvement in the Clinical Course of Systemic Sclerosis. JCM 2022;11:966. [DOI: 10.3390/jcm11040966] [Reference Citation Analysis]
8 Navarroza AMC, Wong SN. Comparison of clinical and metabolic profiles of lean versus non-lean nonalcoholic fatty liver disease. Indian J Gastroenterol 2021. [PMID: 34213749 DOI: 10.1007/s12664-021-01184-6] [Reference Citation Analysis]
9 Lonardo A, Targher G. Cardiovascular Risk in NAFLD: An Intimate Relationship? Dig Dis Sci 2020;65:1593-5. [DOI: 10.1007/s10620-019-05996-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
10 Alam S, Eslam M, Skm Hasan N, Anam K, Chowdhury MAB, Khan MAS, Hasan MJ, Mohamed R. Risk factors of nonalcoholic fatty liver disease in lean body mass population: A systematic review and meta-analysis. JGH Open 2021;5:1236-49. [PMID: 34816009 DOI: 10.1002/jgh3.12658] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]